Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artholeve Ult is a multi-ingredient dietary supplement developed by Nature's Field, specifically formulated to support joint health, flexibility, and comfort. It contains a high-potency blend of glucosamine hydrochloride, chondroitin sulfate, methylsulfonylmethane (MSM), and hyaluronic acid. Glucosamine and chondroitin serve as essential structural components of glycosaminoglycans in the cartilage matrix, helping to maintain joint integrity and resist compression. MSM provides a source of organic sulfur necessary for collagen production and exerts anti-inflammatory effects by inhibiting the NF-kappaB signaling pathway. Hyaluronic acid acts as a key component of synovial fluid, enhancing lubrication and shock absorption within the joint capsule. Artholeve Ult is primarily indicated for individuals suffering from osteoarthritis, joint stiffness, or age-related joint degradation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Artholeve Ult.